Disease Prevention

EU approves its first vaccine for common respiratory virus RSV European regulators have approved the region's first vaccine for respiratory syncytial virus (RSV), which causes thousands of hospitalisations and deaths annually. Natalie Grover,Eva Mathews Reuters

...

Four communication lessons we learned the hard way during the pandemic The first lesson we learned the hard way during the pandemic: Don't assume science is enough. Torie Bosch STAT

...

While our pandemic behavior changes are big accomplishments, it’s undeniable that communication has also at times been confusing, inconsistent, or ineffective. Here are four clear lessons the public health community should take with us to help ensure our messages connect with our audience.

...

How Covid made it nearly impossible to pass new vaccine rules Around the country, vaccine policy is on hold while lawmakers recover from a pandemic-policy hangover. POLITICO

...

Toxic, pandemic-era battles over immunizations and school closures have made vaccine politics radioactive, even on diseases wholly unrelated to Covid-19. In California, where lawmakers pushed through some of the nation’s strictest mandates through 2019, schools are wary of wading back into the fight.

FDA approves Pfizer RSV vaccine for older adults The Food and Drug Administration (FDA) on Wednesday approved Pfizer’s vaccine to prevent the respiratory disease RSV in older adults, the company announced. After decades without any RSV shot… nweixel The Hill

...

The approval of Pfizer’s Abrysvo marks the second authorized RSV shot for older adults in the U.S. this month, after GlaxoSmithKline (GSK) won approval for its rival shot, Arexvy.